Relmada Therapeutics, Inc. RLMD Prepaid expenses
Prepaid expenses at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s prepaid expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s prepaid expenses?
- Relmada Therapeutics, Inc. (RLMD) reported prepaid expenses of $1.38M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s prepaid expenses changed year-over-year?
- Relmada Therapeutics, Inc.'s prepaid expenses increased by 131.4% year-over-year, from $596.41K to $1.38M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s prepaid expenses?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s prepaid expenses has grown at a 1.6% compound annual growth rate (CAGR), from $903.19K to $977.72K.